Welcome to LookChem.com Sign In|Join Free

CAS

  • or

195533-53-0

Post Buying Request

195533-53-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

195533-53-0 Usage

Description

Unii-T4np8G3K6q, also known as Glycerol, is a simple polyol compound that is widely used in various industries due to its unique properties. It is a colorless, odorless, and viscous liquid with a sweet taste. Glycerol is hygroscopic, which means it can absorb moisture from the environment, and it is also a versatile solvent for various substances. Its chemical structure allows it to form hydrogen bonds with other molecules, making it a valuable component in many applications.

Uses

Used in Pharmaceutical Industry:
Unii-T4np8G3K6q is used as a solvent for various pharmaceutical applications, such as the formulation of drugs, elixirs, and oral and topical medications. Its ability to dissolve a wide range of substances, including active pharmaceutical ingredients, makes it an ideal choice for drug formulation.
Used in Cosmetics and Personal Care Industry:
In the cosmetics and personal care industry, Unii-T4np8G3K6q is used as a humectant to help retain moisture in skincare products, hair care products, and oral care products. Its hygroscopic nature helps to keep the products effective and maintain their consistency.
Used in Food and Beverage Industry:
Unii-T4np8G3K6q is used as a humectant, emulsifier, and sweetener in the food and beverage industry. It helps to maintain the moisture content in foods, improve the texture of baked goods, and enhance the taste of various products.
Used in Treatment of Various Refractory Cancers:
Unii-T4np8G3K6q is used in the treatment of various refractory cancers, including hepatocellular carcinoma, breast, colon, and non-small cell lung cancer. Its application in this field is due to its potential to enhance the efficacy of conventional chemotherapeutic drugs and improve chemo-sensitivity in resistant cases.
Used in Anticancer Applications:
Unii-T4np8G3K6q is employed as an anticancer agent, modulating several oncological signaling pathways and exerting inhibitory effects on tumor growth and progression.
Used in Drug Delivery Systems:
To overcome the limitations of Unii-T4np8G3K6q, novel drug delivery systems have been developed to enhance its applications and efficacy against cancer cells. Various organic and metallic nanoparticles have been employed as carriers for Unii-T4np8G3K6q delivery, aiming to improve its delivery, bioavailability, and therapeutic outcomes.

Check Digit Verification of cas no

The CAS Registry Mumber 195533-53-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,5,5,3 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 195533-53:
(8*1)+(7*9)+(6*5)+(5*5)+(4*3)+(3*3)+(2*5)+(1*3)=160
160 % 10 = 0
So 195533-53-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H7F6NO3S/c1-23-7-3-2-5(4-6(7)14)20-24(21,22)13-11(18)9(16)8(15)10(17)12(13)19/h2-4,20H,1H3

195533-53-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxyphenyl)benzenesulfonamide

1.2 Other means of identification

Product number -
Other names Batabulin [INN]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:195533-53-0 SDS

195533-53-0Relevant articles and documents

PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF

-

Paragraph 00249, (2021/05/29)

Provided herein are pentafluorobenzenesulfonamide compounds of Formula (I), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases. These compounds are covalent small molecule inhibitors,

Synthesis, Biodistribution and Micro-PET Imaging of Potential Cancer Biomarkers Radiolabelled Antimitotic Agents [11C]T138067 and [18F]T138067

Fei, X.,Zheng, Q.-H.,Wang, J.-Q.,Stone, K. L.,Martinez, T. D.,Gay, D. J.,Baity, W. L.,Mock, B. H.,Glick-Wilson, B. E.,Sullivan, M. L.,Miller, K. D.,et al.

, p. S113 - S113 (2007/10/03)

-

Pentafluorobenzenesulfonamides and analogs

-

, (2008/06/13)

The invention provides methods and compositions relating to novel pentafluorophenylsulfonamide derivatives and analogs and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents. The compositions include compounds of the general formula I: STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 195533-53-0